The WHO approves lenacapavir every six months as a new step in HIV prevention, simplifying diagnoses and expanding ...

The WHO issued guidance on long-acting lenacapavir and RDTs to support HIV PrEP implementation and simplified testing ...

Researchers at the German Center for Infection Research (DZIF) at Heidelberg University Hospital have decoded a previously ...

Lenacapavir has the potential to end the HIV epidemic, researchers say. The Trump administration says backing this kind of ...

A once-daily oral combination therapy for HIV — bictegravir plus lenacapavir — is more effective than complex regimens are, according to results from a phase 2 study of people with HIV who are ...

In a new Johns Hopkins Medicine-led study, researchers predict that ending federal funding for the Ryan White Program could ...

The discovery of broadly neutralizing antibodies (bNAbs) like b12 in 1994 marked a turning point in HIV research. B12 ...

Despite medical advancements, HIV remains a serious public health issue in the United States, with about 30,000 new diagnoses reported each year, according to federal data. Dr. Andrew See, a ...

Net health care costs would also increase by billions of dollars should pre-exposure prophylaxis become less accessible.

KUALA LUMPUR, Malaysia — The World Health Organization has unveiled its much-anticipated new HIV treatment guidelines. Officials say the new approach will prevent 3 million deaths by 2025 and will ...

When the U.S. Congress passed the Ryan White Comprehensive AIDS Resources Emergency (CARE) Act in August 1990, it honored a ...